ArticleInternational journal of clinical oncology2013

Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment.

Tomoko Ogawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.